You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0010 Effect of denosumab compared with risedronate in glucocorticoid-treated individuals: results from the 12-month primary analysis of a randomized, double-blind, active-controlled study

Citation Tools

Article menu

Download PDFPDF

Oral Presentations
Assessment and management of osteoporosis
OP0010 Effect of denosumab compared with risedronate in glucocorticoid-treated individuals: results from the 12-month primary analysis of a randomized, double-blind, active-controlled study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Saag K, Wagman R, Geusens P, et al
OP0010 Effect of denosumab compared with risedronate in glucocorticoid-treated individuals: results from the 12-month primary analysis of a randomized, double-blind, active-controlled study
Annals of the Rheumatic Diseases 2017;76:54.